Hydroxyprogesterone caproate medicines to be suspended from the EU market

View source ↗

Summary

The European Medicines Agency will suspend hydroxyprogesterone caproate medicines in the EU after a review found possible safety concerns and no evidence that t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Hydroxyprogesterone caproate (hydroxyprogesterone caproate)

Snippet

Review of studies raises possible safety concern and finds no effect in preventing premature birth